News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week in Review: Tasly Pharmaceutical Buys Stake in TCM Maker for $25 Million


10/7/2013 8:19:48 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

October 5, 2013 --Tianjin Tasly Pharma acquired a 45% stake in Henan New Century Pharmaceutical for $24.7 million; Hefei Life Science Park will fund the China clinical development of a drug eluting stent produced by Micell Technologies, a North Carolina device maker; Sanofi is taking the “big picture” approach to emerging markets, continuing to invest despite drug price reductions and accusations of bribery; Parexel, the US clinical-stage CRO, has formed a Beijing company that is dedicated entirely to conducting trials that will gain product approvals in China; Lee's Pharma of Hong Kong said its China registration study of Trazodone as a treatment for depression met its primary endpoint. More details….

Stock Symbols: (SHA: 600535) (NYSE: SNY) (NSDQ: PRXL) (HK: 0950)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES